{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:31:57Z","timestamp":1791048717357,"version":"4.1.0"},"reference-count":80,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T00:00:00Z","timestamp":1364428800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0060047","type":"journal-article","created":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T21:07:52Z","timestamp":1364504872000},"page":"e60047","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":134,"title":["Antifungal Efficacy during Candida krusei Infection in Non-Conventional Models Correlates with the Yeast In Vitro Susceptibility Profile"],"prefix":"10.1371","volume":"8","author":[{"given":"Liliana","family":"Scorzoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pilar","family":"de Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cecilia","family":"Mesa-Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Marisa","family":"Fusco-Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Encarnaci\u00f3n","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Cuenca-Estrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Mendes-Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Zaragoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,3,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"MA Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1128\/JCM.43.4.1829-1835.2005","article-title":"Epidemiology and predictors of mortality in cases of <italic>Candida<\/italic> bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003","volume":"43","author":"B Almirante","year":"2005","journal-title":"J Clin Microbiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3201\/eid1210.060389","article-title":"Active surveillance for candidemia, Australia","volume":"12","author":"S Chen","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1097\/CCM.0b013e31818b3477","article-title":"Treatment-related risk factors for hospital mortality in <italic>Candida<\/italic> bloodstream infections","volume":"36","author":"AJ Labelle","year":"2008","journal-title":"Crit Care Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408410903241444","article-title":"Epidemiology of invasive mycoses in North America","volume":"36","author":"MA Pfaller","year":"2010","journal-title":"Crit Rev Microbiol"},{"key":"ref6","first-page":"785","article-title":"Epidemiology of endemic systemic fungal infections in Latin America","volume":"49","author":"AL Colombo","year":"2011","journal-title":"Med Mycol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/13693780601009493","article-title":"Fungal diseases: an evolving public health challenge","volume":"44","author":"DW Warnock","year":"2006","journal-title":"Med Mycol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1097\/CCM.0b013e3181a0f95d","article-title":"Burden of early-onset candidemia: analysis of culture-positive bloodstream infections from a large U.S. database","volume":"37","author":"AF Shorr","year":"2009","journal-title":"Crit Care Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(03)00801-6","article-title":"Epidemiology of <italic>Candida<\/italic> species infections in critically ill non-immunosuppressed patients","volume":"3","author":"P Eggimann","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1128\/JCM.00773-06","article-title":"Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers","volume":"44","author":"AL Colombo","year":"2006","journal-title":"J Clin Microbiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ijantimicag.2007.07.019","article-title":"Recent advances and challenges in the treatment of invasive fungal infections","volume":"30","author":"PL Shao","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"ref12","first-page":"90","article-title":"General epidemiology of invasive fungal disease","volume":"30","author":"J Pem\u00e1n","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MCC.0b013e32833e84d2","article-title":"Epidemiology of invasive candidiasis","volume":"16","author":"MC Arendrup","year":"2010","journal-title":"Curr Opin Crit Care"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/jac\/dks019","article-title":"Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey","volume":"67","author":"J Peman","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1086\/342300","article-title":"Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989\u20131999","volume":"35","author":"WE Trick","year":"2002","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/JCM.01915-07","article-title":"<italic>Candida krusei<\/italic>, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005","volume":"46","author":"MA Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1086\/599039","article-title":"Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry","volume":"48","author":"DL Horn","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1473-3099(10)70218-8","article-title":"Emerging opportunistic yeast infections","volume":"11","author":"MH Miceli","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1358\/dnp.2010.23.2.1400855","article-title":"EUCAST breakpoints for antifungals","volume":"23","author":"JL Rodr\u00edguez-Tudela","year":"2010","journal-title":"Drug News Perspect"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1001\/archinte.160.17.2659","article-title":"<italic>Candida krusei<\/italic> fungemia. An escalating serious infection in immunocompromised patients","volume":"160","author":"J Abbas","year":"2000","journal-title":"Arch Intern Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1128\/AAC.47.4.1213-1219.2003","article-title":"Genetic basis for differential activities of fluconazole and voriconazole against <italic>Candida krusei<\/italic>","volume":"47","author":"T Fukuoka","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","article-title":"Guidelines for treatment of candidiasis","volume":"38","author":"PG Pappas","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1086\/507891","article-title":"New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage","volume":"43","author":"EK Spanakis","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1128\/AAC.40.11.2443","article-title":"Reduced accumulation of drug in <italic>Candida kruse<\/italic>i accounts for itraconazole resistance","volume":"40","author":"K Venkateswarlu","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1128\/AAC.42.10.2645","article-title":"Mechanism of fluconazole resistance in <italic>Candida krusei<\/italic>","volume":"42","author":"AS Orozco","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"ref26","first-page":"30","article-title":"Epidemiology of candidemia in Spain - Multicenter study","volume":"19","author":"J Pem\u00e1n","year":"2002","journal-title":"Rev Iberoam Micol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jac\/dkh532","article-title":"<italic>Candida krusei<\/italic> fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital","volume":"55","author":"P Mu\u00f1oz","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijantimicag.2006.03.012","article-title":"Antifungal drug resistance: limited data, dramatic impact?","volume":"27 Suppl 1","author":"TR Rogers","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/S0924-8579(08)70010-4","article-title":"Clinical relevance of resistance to antifungals","volume":"32 Suppl 2","author":"JL Rodriguez-Tudela","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1128\/AAC.00911-09","article-title":"Caspofungin use in patients with invasive candidiasis caused by common non-albicans <italic>Candida<\/italic> species: review of the caspofungin database","volume":"54","author":"AL Colombo","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"15245","DOI":"10.1073\/pnas.261418798","article-title":"<italic>Cryptococcus neoformans<\/italic> interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages","volume":"98","author":"JN Steenbergen","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1128\/IAI.71.9.4862-4872.2003","article-title":"<italic>Cryptococcus neoformans<\/italic> virulence is enhanced after growth in the genetically malleable host <italic>Dictyostelium discoideum<\/italic>","volume":"71","author":"JN Steenbergen","year":"2003","journal-title":"Infect Immun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"15675","DOI":"10.1073\/pnas.232568599","article-title":"Killing of <italic>Caenorhabditis elegan<\/italic>s by <italic>Cryptococcus neoformans<\/italic> as a model of yeast pathogenesis","volume":"99","author":"E Mylonakis","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-4419-5638-5_2","article-title":"Of model hosts and man: using <italic>Caenorhabditis elegans<\/italic>, <italic>Drosophila melanogaste<\/italic>r and <italic>Galleria mellonella<\/italic> as model hosts for infectious disease research","volume":"710","author":"J Glavis-Bloom","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.4049\/jimmunol.172.9.5622","article-title":"Immune-deficient <italic>Drosophila melanogaste<\/italic>r: a model for the innate immune response to human fungal pathogens","volume":"172","author":"AM Alarco","year":"2004","journal-title":"J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0965-1748(00)00146-6","article-title":"Exploration of mosquito immunity using cells in culture","volume":"31","author":"AM Fallon","year":"2001","journal-title":"Insect Biochem Mol Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev.mi.41.100187.000535","article-title":"Cell-free immunity in insects","volume":"41","author":"HG Boman","year":"1987","journal-title":"Annu Rev Microbiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.femsre.2003.09.002","article-title":"Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens","volume":"28","author":"K Kavanagh","year":"2004","journal-title":"FEMS Microbiol Rev"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.micinf.2003.09.019","article-title":"Fluctuations in haemocyte density and microbial load may be used as indicators of fungal pathogenicity in larvae of <italic>Galleria mellonella<\/italic>","volume":"5","author":"D Bergin","year":"2003","journal-title":"Microbes Infect"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4161\/viru.1.6.12985","article-title":"Methods for using <italic>Galleria mellonella<\/italic> as a model host to study fungal pathogenesis","volume":"1","author":"BB Fuchs","year":"2010","journal-title":"Virulence"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e1002451","DOI":"10.1371\/journal.ppat.1002451","article-title":"Selecting an invertebrate model host for the study of fungal pathogenesis","volume":"8","author":"A Desalermos","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.mib.2006.06.004","article-title":"Using non-mammalian hosts to study fungal virulence and host defense","volume":"9","author":"BB Fuchs","year":"2006","journal-title":"Curr Opin Microbiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0092-8674(00)80958-7","article-title":"Molecular mechanisms of bacterial virulence elucidated using a <italic>Pseudomonas aeruginosa-Caenorhabditis elegans<\/italic> pathogenesis model","volume":"96","author":"S Mahajan-Miklos","year":"1999","journal-title":"Cell"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1371\/journal.ppat.0030018","article-title":"Antifungal chemical compounds identified using a <italic>C. elegans<\/italic> pathogenicity assay","volume":"3","author":"J Breger","year":"2007","journal-title":"PLoS Pathog"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1038\/nprot.2008.193","article-title":"A <italic>C. elegans<\/italic>-based, whole animal, in vivo screen for the identification of antifungal compounds","volume":"3","author":"E Tampakakis","year":"2008","journal-title":"Nat Protoc"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e7025","DOI":"10.1371\/journal.pone.0007025","article-title":"Identification of antifungal compounds active against <italic>Candida albicans<\/italic> using an improved high-throughput <italic>Caenorhabditis elegans<\/italic> assay","volume":"4","author":"I Okoli","year":"2009","journal-title":"PLoS One"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00328721","article-title":"Isolation of the <italic>Candida albicans<\/italic> gene for orotidine-5\u2032-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations","volume":"198","author":"AM Gillum","year":"1984","journal-title":"Mol Gen Genet"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1469-0691.2007.01935.x","article-title":"EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts","volume":"14","author":"JL Rodriguez-Tudela","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1111\/j.1469-0691.2012.03880.x","article-title":"EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)","volume":"18","author":"MC Arendrup","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"ref50","first-page":"150","article-title":"Laccase activity in <italic>Cryptococcus gattii<\/italic> strains isolated from goats","volume":"25","author":"E Alvarado-Ramirez","year":"2008","journal-title":"Rev Iberoam Micol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1128\/jb.176.3.656-664.1994","article-title":"Biochemical and molecular characterization of the diphenol oxidase of <italic>Cryptococcus neoformans<\/italic>: identification as a laccase","volume":"176","author":"PR Williamson","year":"1994","journal-title":"J Bacteriol"},{"key":"ref52","unstructured":"Sulston J, Hodgkin J (1988) The Nematode <italic>Caenorhabditis elegans<\/italic>. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press."},{"key":"ref53","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.micinf.2010.03.001","article-title":"Role of filamentation in <italic>Galleria mellonella<\/italic> killing by <italic>Candida albicans<\/italic>","volume":"12","author":"BB Fuchs","year":"2010","journal-title":"Microbes Infect"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1086\/589290","article-title":"Immunocompromised hosts: immunopharmacology of modern antifungals","volume":"47","author":"R Ben-Ami","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1099\/jmm.0.025494-0","article-title":"Caspofungin primes the immune response of the larvae of <italic>Galleria mellonella<\/italic> and induces a non-specific antimicrobial response","volume":"60","author":"J Kelly","year":"2011","journal-title":"J Med Microbiol"},{"key":"ref56","first-page":"286","article-title":"It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug","volume":"3","author":"AC Mesa-Arango","year":"2012","journal-title":"Frontiers in Microbiology"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1371\/journal.ppat.0030101","article-title":"Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi","volume":"3","author":"E Mylonakis","year":"2007","journal-title":"PLoS Pathog"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"e24485","DOI":"10.1371\/journal.pone.0024485","article-title":"<italic>Cryptococcus neoformans<\/italic> capsular enlargement and cellular gigantism during <italic>Galleria mellonella<\/italic> infection","volume":"6","author":"R Garc\u00eda-Rodas","year":"2011","journal-title":"PLoS One"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"e1002074","DOI":"10.1371\/journal.ppat.1002074","article-title":"<italic>Candida albicans<\/italic> infection of <italic>Caenorhabditis elegans<\/italic> induces antifungal immune defenses","volume":"7","author":"R Pukkila-Worley","year":"2011","journal-title":"PLoS Pathog"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"e4224","DOI":"10.1371\/journal.pone.0004224","article-title":"Conidiation color mutants of <italic>Aspergillus fumigatus<\/italic> are highly pathogenic to the heterologous insect host <italic>Galleria mellonella<\/italic>","volume":"4","author":"JC Jackson","year":"2009","journal-title":"PLoS One"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s15010-002-2131-0","article-title":"In vivo pathogenicity of eight medically relevant <italic>Candida<\/italic> species in an animal model","volume":"30","author":"M Arendrup","year":"2002","journal-title":"Infection"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1574-695X.2000.tb01427.x","article-title":"Development of an insect model for the in vivo pathogenicity testing of yeasts","volume":"27","author":"G Cotter","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/infdis\/168.5.1311","article-title":"Comparison of the efficacy of polyenes and triazoles against hematogenous <italic>Candida krusei<\/italic> infection in neutropenic mice","volume":"168","author":"NC Karyotakis","year":"1993","journal-title":"J Infect Dis"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jac\/dkn431","article-title":"Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated <italic>Candida tropicalis<\/italic> and <italic>Candida krusei<\/italic>","volume":"63","author":"J Majithiya","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11046-010-9368-4","article-title":"<italic>Galleria mellonella<\/italic> are resistant to <italic>Pneumocystis murina<\/italic> infection","volume":"171","author":"BB Fuchs","year":"2011","journal-title":"Mycopathologia"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1128\/IAI.73.7.3842-3850.2005","article-title":"<italic>Galleria mellonella<\/italic> as a model system to study <italic>Cryptococcus neoformans<\/italic> pathogenesis","volume":"73","author":"E Mylonakis","year":"2005","journal-title":"Infect Immun"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.funbio.2011.09.005","article-title":"<italic>Fusarium<\/italic> pathogenesis investigated using <italic>Galleria mellonella<\/italic> as a heterologous host","volume":"115","author":"JJ Coleman","year":"2011","journal-title":"Fungal Biol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0966-842X(01)02035-2","article-title":"Intracellular parasitism of macrophages by <italic>Cryptococcus neoformans<\/italic>","volume":"9","author":"M Feldmesser","year":"2001","journal-title":"Trends Microbiol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1574-695X.2011.00871.x","article-title":"Catch me if you can: phagocytosis and killing avoidance by <italic>Cryptococcus neoformans<\/italic>","volume":"64","author":"R Garcia-Rodas","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref70","article-title":"The non-mammalian host <italic>Galleria mellonella<\/italic> can be used to study the virulence of the fungal pathogen <italic>Candida tropicalis<\/italic> and the efficacy of antifungal drugs during infection by this pathogenic yeast","author":"AC Mesa-Arango","year":"2012","journal-title":"Med Mycol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10534-008-9182-3","article-title":"Use of <italic>Galleria mellonella<\/italic> larvae to evaluate the in vivo anti-fungal activity of [Ag2(mal)(phen)3]","volume":"22","author":"R Rowan","year":"2009","journal-title":"Biometals"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000168009","article-title":"Activation of insect phenoloxidase after injury: endogenous versus foreign elicitors","volume":"1","author":"G Bidla","year":"2009","journal-title":"J Innate Immun"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/infdis\/170.2.384","article-title":"Correlation between in vitro and in vivo activity of antifungal agents against <italic>Candida<\/italic> species","volume":"170","author":"EJ Anaissie","year":"1994","journal-title":"J Infect Dis"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"e25321","DOI":"10.1371\/journal.pone.0025321","article-title":"Antifungal activity of microbial secondary metabolites","volume":"6","author":"JJ Coleman","year":"2011","journal-title":"PLoS One"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1517\/17460441.2011.573781","article-title":"Using <italic>C. elegans<\/italic> for antimicrobial drug discovery","volume":"6","author":"A Desalermos","year":"2011","journal-title":"Expert Opin Drug Discov"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1021\/cb900243b","article-title":"Characterization of plant-derived saponin natural products against <italic>Candida albicans<\/italic>","volume":"5","author":"JJ Coleman","year":"2010","journal-title":"ACS Chem Biol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10096-004-1174-9","article-title":"In vitro activity of voriconazole and other antifungal agents against clinical isolates of <italic>Candida glabrata<\/italic> and <italic>Candida krusei<\/italic>","volume":"23","author":"M Drago","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jac\/dkh532","article-title":"<italic>Candida krusei<\/italic> fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital","volume":"55","author":"P Munoz","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1128\/AAC.00955-08","article-title":"Activity of anidulafungin in a murine model of <italic>Candida krusei<\/italic> infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1,3)-beta-D-glucan levels","volume":"53","author":"L Ostrosky-Zeichner","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3109\/13693786.2011.648217","article-title":"The role of mycelium production and a MAPK-mediated immune response in the <italic>C. elegans<\/italic>-<italic>Fusarium<\/italic> model system","volume":"50","author":"M Muhammed","year":"2012","journal-title":"Med Mycol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0060047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T14:06:03Z","timestamp":1562853963000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0060047"}},"subtitle":[],"editor":[{"given":"Gustavo Henrique","family":"Goldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,28]]},"references-count":80,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0060047","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,28]]}}}